HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
198533.0,298618,2179-09-16 07:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Gen- AOx3, NAD
   HEENT- NCAT, no JVD, +scleral icterus
   Pulm- B/L posterior rales, equal BS b/l.  Prolonged inspiratory phase,
   with short expiratory phase
   CV- S1/S2 no MGR
   Abd- soft, NTND
   Ext- 1+ LE edema b/l
   Skin -jaundiced
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor in PM
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Gen- AOx3, NAD
   HEENT- NCAT, no JVD, +scleral icterus
   Pulm- B/L posterior rales, equal BS b/l.  Prolonged inspiratory phase,
   with short expiratory phase
   CV- S1/S2 no MGR
   Abd- soft, NTND
   Ext- 1+ LE edema b/l
   Skin -jaundiced
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor in PM<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with cirrhosis, chronic thrombocytopenia, chronic renal failure, and bilateral pneumothorax (PTX) with a new left pleural effusion. He was admitted with unstable vital signs, including hypotension and tachycardia, and is currently receiving 100% non-rebreather oxygen to enhance resorption of PTX. He has been on new medication for thrombocytopenia, but the etiology of the PTX is unclear.

The patient's vital signs are stable, with a heart rate of 66 bpm, blood pressure of 114/51 mmHg, and oxygen saturation of 98%. His respiratory support includes a non-rebreather mask, and his physical examination reveals bilateral posterior rales, equal breath sounds, and prolonged inspiratory phase with a short expiratory phase.

Laboratory results show a white blood cell count of 38,000/uL, hemoglobin of 11.1 g/dL, and platelet count of 47,000/uL. His liver function tests are abnormal, with an aspartate aminotransferase (AST) of 52 IU/L and alkaline phosphatase of 72 IU/L. His blood urea nitrogen (BUN) and creatinine are elevated, indicating chronic renal failure.

Potential medical complications:

1. Respiratory failure: The patient's bilateral PTX and pleural effusion may lead to respiratory failure if not managed promptly.
2. Hemodynamic compromise: The patient's hypotension and tachycardia may indicate hemodynamic compromise, which could worsen if not addressed.
3. Infection: The patient's pleural effusion may be infectious in nature, and the patient is at risk for developing pneumonia or other infections.
4. Bleeding: The patient's thrombocytopenia and abnormal liver function tests may increase his risk of bleeding.
5. Cardiac complications: The patient's cirrhosis and chronic renal failure may increase his risk of cardiac complications, such as heart failure or arrhythmias.

Plan:

1. Continue 100% non-rebreather oxygen to enhance resorption of PTX.
2. Monitor the patient's vital signs and respiratory status closely.
3. Perform a thoracentesis to determine the nature of the pleural effusion.
4. Consider transfusing platelets if the patient's platelet count remains low.
5. Monitor the patient's liver function tests and adjust his medication regimen as necessary.
6. Consider consulting a cardiologist to evaluate the patient's cardiac status.
7. Monitor the patient's renal function and adjust his medication regimen as necessary.
8. Consider transferring the patient to a floor bed when stable."
198533.0,298618,2179-09-16 07:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress in the ICU as follows:

The patient is a 56-year-old male with cirrhosis of the liver, chronic thrombocytopenia, and chronic renal failure. He was admitted with bilateral pneumothorax (PTX) and a new left pleural effusion. The patient has no known underlying lung disease, but he has a mild bullous disease on chest CT, which is out of proportion to his smoking history.

The patient's vital signs are stable, with a temperature of 37.2°C (98.9°F), heart rate of 66 beats per minute, and blood pressure of 114/51 mmHg. His respiratory rate is 12 breaths per minute, and his oxygen saturation is 98% on non-rebreather therapy.

The patient's laboratory results show a white blood cell count of 5.2 K/μL, hemoglobin of 11.1 g/dL, and platelet count of 47 K/μL. His liver enzymes are elevated, with an aspartate aminotransferase (AST) of 52 IU/L and alanine aminotransferase (ALT) of 26 IU/L.

The patient's imaging studies show a small apical pneumothorax on both sides, as well as a left pleural effusion. His microbiology results are pending.

The patient's assessment and plan include:

1. Bilateral pneumothorax: The etiology of the new onset bilateral PTX is unclear, and the patient is being treated with 100% non-rebreather therapy to enhance resorption of the PTX.
2. Pleural effusion: The patient has a new moderate to large left pleural effusion, which may be related to the PTX or may be a separate entity. The patient will undergo a thoracentesis to determine the transudate vs exudate with cytology, cell counts, and Gram stain.
3. Anemia: The patient's hemoglobin has dropped from 36 to 30, and the etiology is unclear. The patient may have bleeding or disseminated intravascular coagulation (DIC).
4. Cardiac enzymes: The patient's cardiac enzymes are negative, and he does not have any ECG changes to suggest ischemia.
5. Cirrhosis: The patient has chronic liver disease, and his cirrhosis is stable. He is being treated with medications to prevent varices and spontaneous bacterial peritonitis.
6. Thrombocytopenia: The patient's platelet count is stable at baseline, and he has been transfused with platelets.
7. Hypertension: The patient's blood pressure is well-controlled on his home medications.

Potential medical complications that can arise from the patient's conditions include:

1. Respiratory failure: The patient's bilateral PTX and pleural effusion may lead to respiratory failure if not managed properly.
2. Bleeding: The patient's thrombocytopenia and anemia may increase his risk of bleeding.
3. Infection: The patient's pleural effusion may be infected, and he may develop sepsis if not treated promptly.
4. Cardiac complications: The patient's cardiac enzymes are negative, but he may still develop cardiac complications such as arrhythmias or heart failure.
5. Liver failure: The patient's cirrhosis may lead to liver failure if not managed properly.
6. Renal failure: The patient's chronic renal failure may worsen if not managed properly.

In conclusion, the patient is a complex case with multiple medical conditions, and he requires close monitoring and management to prevent potential complications."
198533.0,298618,2179-09-17 07:16:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with cirrhosis of the liver, chronic thrombocytopenia, and chronic renal failure. He was admitted with bilateral pneumothorax (PTX) and a new left pleural effusion. The etiology of the PTX is unclear, but it is possible that it is related to rupture of a subpleural bleb or a side effect of a new medication. The patient is being treated with 100% oxygen by nasal cannula and will undergo serial exams and repeat chest X-rays to monitor for any signs of hemodynamic compromise.

The patient also has a new moderate to large left pleural effusion, which is unclear whether it is related to the PTX or not. The differential diagnosis includes hemothorax, empyema, parapneumonic effusion, and transudative effusion. The patient will undergo a thoracentesis to determine the type of effusion and to rule out infectious causes.

The patient has anemia, which is unclear whether it is due to bleeding or disseminated intravascular coagulation (DIC). The DIC labs are normal, and the patient is being treated with fresh frozen plasma (FFP) and will have his coagulation studies monitored.

The patient has dyspnea and chest pain, which are likely secondary to the PTX. He is being treated with morphine and will have his ECG repeated in the morning.

Potential medical complications that can arise:

1. Respiratory failure: The patient's bilateral PTX and pleural effusion can lead to respiratory failure if not properly managed.
2. Hemodynamic compromise: The patient's anemia and potential bleeding can lead to hemodynamic compromise, which can be exacerbated by the PTX.
3. Infection: The patient's pleural effusion can become infected, leading to empyema or parapneumonic effusion.
4. Coagulopathy: The patient's thrombocytopenia and potential DIC can lead to coagulopathy, which can increase the risk of bleeding.
5. Liver failure: The patient's cirrhosis can lead to liver failure, which can be exacerbated by the PTX and pleural effusion.
6. Renal failure: The patient's chronic renal failure can worsen if not properly managed.
7. Cardiovascular complications: The patient's heart disease can lead to cardiovascular complications, such as heart failure or arrhythmias."
198533.0,298618,2179-09-17 07:16:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Gen-AOx3, NAD
   HEENT- scleral icterus, NCAT
   Pulm- crackles on L posterior lung, bilaterally equal lung expansion
   CV- RRR no mgr
   Abd- soft, NTND
   Ext- 1+LE edema
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Gen-AOx3, NAD
   HEENT- scleral icterus, NCAT
   Pulm- crackles on L posterior lung, bilaterally equal lung expansion
   CV- RRR no mgr
   Abd- soft, NTND
   Ext- 1+LE edema
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with cirrhosis, chronic thrombocytopenia, and chronic renal failure, admitted with bilateral pneumothorax (PTX) and a new moderate to large left pleural effusion. The etiology of the PTX is unclear, and the patient has no known underlying lung disease. The patient is currently receiving 100% nasal oxygen therapy and has been prescribed medications to enhance resorption of the PTX.

The patient's physical examination reveals scleral icterus, NCAT, and bilateral equal lung expansion with crackles on the left posterior lung. Laboratory results show thrombocytopenia, anemia, and elevated liver enzymes. The patient has a history of hepatitis C, and his liver function is stable.

The patient's respiratory support includes 100% nasal oxygen therapy, and his vital signs are stable, with a temperature of 37.4°C, heart rate of 69 beats per minute, and blood pressure of 98/58 mmHg.

Potential medical complications:

1. Pneumothorax: The patient's bilateral PTX may worsen, leading to respiratory compromise, or the left PTX may expand, causing respiratory failure.
2. Pleural effusion: The patient's left pleural effusion may continue to worsen, causing respiratory compromise, or the effusion may become infected, leading to empyema.
3. Thrombocytopenia: The patient's thrombocytopenia may worsen, leading to bleeding complications or increased risk of infection.
4. Anemia: The patient's anemia may worsen, leading to fatigue, weakness, and decreased oxygen delivery to tissues.
5. Hepatic encephalopathy: The patient's liver disease may worsen, leading to hepatic encephalopathy, a life-threatening condition characterized by altered mental status, confusion, and coma.
6. Respiratory failure: The patient's respiratory compromise may worsen, leading to respiratory failure, requiring mechanical ventilation.
7. Cardiac complications: The patient's underlying cardiac disease may worsen, leading to cardiac complications, such as heart failure, arrhythmias, or cardiogenic shock.

Recommendations:

1. Continue 100% nasal oxygen therapy to enhance resorption of the PTX.
2. Monitor the patient's respiratory status closely, and consider intubation if respiratory compromise worsens.
3. Perform a thoracentesis to determine the nature of the pleural effusion and to rule out infection.
4. Monitor the patient's thrombocytopenia and anemia, and consider transfusions if necessary.
5. Monitor the patient's liver function and consider antibiotics if there is evidence of liver infection.
6. Consider transfer to a cardiothoracic intensive care unit if the patient's respiratory status worsens or if cardiac complications develop."
